Arm Holdings plc vs Stryker Corporation — how do they compare? Arm Holdings plc trades at $271.73 (market cap $287.22B), while Stryker Corporation trades at $346.82 (market cap $133.54B). The key difference: Arm Holdings plc is far larger — about 2.2× Stryker Corporation's market cap, and Stryker Corporation pays a 1.01% dividend while Arm Holdings plc pays none. Which is the better fit depends on your goals.
| ARM | SYK | |
|---|---|---|
Market Cap | $287.22B | $133.54B |
Sector | Technology | Technology |
52-Week High | $439.46 | $394.34 |
52-Week Low | $104.55 | $282.58 |
Enterprise Value | $283.79B | $145.01B |
Dividend Yield | — | 1.01% |
Signals from Pluang's Aura AI — not financial advice
ARM stock trades at $271.87, up 1.5% in the last 24 hours, with a bullish technical signal and strong quarterly earnings beats. The company reported robust revenue growth, reaching $4.01 billion in 2025, with a net income margin of 20.25%. Recent news highlights AI-driven optimism, though valuation metrics like a P/E of 274.42 indicate premium pricing.
Outlook is positive with analyst consensus favoring a buy rating (70.37%) and a $329.80 price target, but risks include high valuation sensitivity and competitive pressures in the smartphone market. Earnings growth from AI and data center demand presents opportunity, yet investors must weigh stretched multiples against execution risks.
Stryker (SYK) trades at $347.21, up 0.4% today, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, including a 9% organic sales growth in Q2 2026 and a net income margin of 14.43%. Recent news highlights recovery from a cybersecurity incident and the launch of Mako RPS, expanding its robotic surgery portfolio. Analyst consensus is overwhelmingly positive, with 74% recommending Buy and a price target of $379.44.
The outlook for SYK is favorable, driven by robust earnings growth and strategic product launches. Key risks include cybersecurity vulnerabilities and margin pressures from tariffs. With no sell ratings and strong institutional support, the stock presents a compelling opportunity for growth-oriented investors, though monitoring quarterly execution remains critical.
Trailing returns across standard periods
Latest headlines on both assets
Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.
Read more on ARM →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →